Seragon Pharmaceuticals seragonpharm.com


Seragon is focused on developing new treatments for estrogen-driven cancers based on its Selective Estrogen Receptor Degrader (SERD) platform. Seragon Pharmaceuticals' orally active selective estrogen receptor degraders (SERDs) represent a potential new treatment for progressive metastatic breast cancer that may circumvent the problem of resistance to anti-hormonal therapies. SERDs are estrogen receptor antagonists that also induce a conformational change that results in the degradation of the r...Show all

Seragon is focused on developing new treatments for estrogen-driven cancers based on its Selective Estrogen Receptor Degrader (SERD) platform. Seragon Pharmaceuticals' orally active selective estrogen receptor degraders (SERDs) represent a potential ...Show all

Company (Acquired)

Phone: 858-369-7600

Fax:

12780 El Camino Real
Suite #302
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Seragon Pharmaceuticals $30M Jul 2, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Seragon Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Estrogen receptor modulators and uses thereof Mar 14, 2013 Nov 22, 2016 Patent
Fluorinated estrogen receptor modulators and uses thereof Dec 14, 2012 Nov 24, 2015 Patent
Estrogen receptor modulators and uses thereof Dec 14, 2012 Nov 17, 2015 Patent
Estrogen receptor modulators and uses thereof Dec 20, 2013 Jul 14, 2015 Patent
Indane estrogen receptor modulators and uses thereof Jun 15, 2011 Oct 07, 2014 Patent
See all 7 patents